Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Fluvoxamine

One of the first SSRI antidepressants, introduced in Switzerland in 1983: it is used for depression and obsessive-compulsive disorder, the indication for which it was approved in the United States in 1994. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?In Japan it was the first SSRI approved, in 1999, and in 2005 it became the first medicine authorised for social anxiety disorder.

Fluvoxamine MaleateGo to the active ingredient →
Fluvoxamine-d4Isotopically labelledFluvoxamine-d4Cat. No. P-F107-024CAS 1432075-73-4

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.